SHORT-TERM EFFECTS OF THE ANTI-ASTHMATIC DRUG, MONTELUKAST, IN FEMALE RATS
Al-Hayder, M., Almiah, Z., Al-Mayyahi, R., Hussein, Q. (2023). SHORT-TERM EFFECTS OF THE ANTI-ASTHMATIC DRUG, MONTELUKAST, IN FEMALE RATS. EKB Journal Management System, 46(1), 507-516. doi: 10.21608/bfsa.2023.301248
Manal N. Al-Hayder; Zahra A. Almiah; Rawaa S. Al-Mayyahi; Qasim A. Hussein. "SHORT-TERM EFFECTS OF THE ANTI-ASTHMATIC DRUG, MONTELUKAST, IN FEMALE RATS". EKB Journal Management System, 46, 1, 2023, 507-516. doi: 10.21608/bfsa.2023.301248
Al-Hayder, M., Almiah, Z., Al-Mayyahi, R., Hussein, Q. (2023). 'SHORT-TERM EFFECTS OF THE ANTI-ASTHMATIC DRUG, MONTELUKAST, IN FEMALE RATS', EKB Journal Management System, 46(1), pp. 507-516. doi: 10.21608/bfsa.2023.301248
Al-Hayder, M., Almiah, Z., Al-Mayyahi, R., Hussein, Q. SHORT-TERM EFFECTS OF THE ANTI-ASTHMATIC DRUG, MONTELUKAST, IN FEMALE RATS. EKB Journal Management System, 2023; 46(1): 507-516. doi: 10.21608/bfsa.2023.301248

SHORT-TERM EFFECTS OF THE ANTI-ASTHMATIC DRUG, MONTELUKAST, IN FEMALE RATS

Bulletin of Pharmaceutical Sciences Assiut University
Volume 46, Issue 1, June 2023, Page 507-516  XML PDF (1.52 MB)
Document Type: Original Article
DOI: 10.21608/bfsa.2023.301248
View on SCiNiTO View on SCiNiTO
Authors
Manal N. Al-Hayder1; Zahra A. Almiahorcid 2; Rawaa S. Al-Mayyahi email 3; Qasim A. Hussein4
1Department of Pharmacology and Toxicology, College of Pharmacy, University of Basrah, Iraq
2Department of Basra Health, Basrah, Iraq
3Department of Clinical Laboratory Science, College of Pharmacy, University of Basrah, Basrah, Iraq
4Basrah General Hospital, Basrah, Iraq
Abstract
Asthma is a chronic disease affecting more than 300 million people worldwide. Rising asthma rates have fuelled a demand for more effort to focus on the possible effects of anti-asthma therapies. Montelukast, a leukotriene receptor antagonist was shown to be an essential mediator of asthma. It has a dual mechanism of action, acting as a bronchodilator and anti-inflammatory. However, such therapy is associated with harmful effects. This study aimed to determine the short term effects following montelukast treatment. A total of twenty female rats were assigned into two equal groups. The control group received vehicle 0.2 ml of saline solution (0.9%), while the treated group received 10 mg/kg/day of montelukast diluted in saline solution 0.9% for five consecutive days. The haematological, biochemical and histopathological analyses were studied. There were no significant differences in haematological analysis and liver enzymes compared with control group. However, there were significant reductions in the levels of total cholesterol, triglyceride and high density lipoprotein compared with control group. Also, several histopathological alterations in rat liver tissues and kidney following montelukast treatment were observed. In conclusion, montelukast has harmful effects even after short treatment periods.
Keywords
Montelukast; Haematology; Histopathology; Lipid profile; Cholesterol; Triglyceride
Statistics
Article View: 229
PDF Download: 256